tolvaptan has been researched along with Brain Hemorrhage in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arima, H; Banno, R; Fujisawa, H; Goto, M; Iwama, S; Izumida, H; Kiyota, A; Nakashima, K; Ochiai, H; Ogawa, K; Oiso, Y; Suga, H; Sugimura, Y; Suzuki, H; Takagi, H; Takeuchi, S | 1 |
1 other study(ies) available for tolvaptan and Brain Hemorrhage
Article | Year |
---|---|
Minocycline prevents osmotic demyelination associated with aquaresis.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 4; Astrocytes; Behavior, Animal; Benzazepines; Biomarkers; Brain; Chemokines; Cytokines; Cytoprotection; Deamino Arginine Vasopressin; Demyelinating Diseases; Disease Models, Animal; Diuresis; Hyponatremia; Intracranial Hemorrhages; Male; Matrix Metalloproteinases; Minocycline; Neuroprotective Agents; Osmosis; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Sodium; Therapeutics; Time Factors; Tolvaptan; Water-Electrolyte Balance | 2014 |